America’s Centers for Disease Control and Prevention has released new data that indicates that the Johnson & Johnson (J&J) vaccine might not protect people against the COVID-19 virus the same way that the other vaccines do.
According to the data made available in the United States, it shows that Pfizer and Moderna’s two-shot vaccines work best at preventing all kinds of COVID-19 infections, Business Insider reports.
Read also: Do COVID-19 and some vaccines actually cause this auto-immune disorder?
The latest information on the J&J vaccines comes at a crucial time where an independent advisory committee to the US Food and Drug Administration (FDA) has agreed that those who have already received one shot, should get another booster shot. However, it doesn’t have to be the same brand.
Peter Marks, FDA’s director at the Center for Biologics Evaluation and Research announced that all of the data gathered do not fully align with this being a vaccine that retains excellent activity overtime against all forms of disease, or even against severe forms of disease.
Meanwhile, South Africa’s Department of Health has recently announced that the vaccination roll-out plan will now extend to children over 12 years old.
Children aged 12 to 17 can get the jab from October 20, News24,reported. The addition of this age group will include an additional six million people to the programme, with the Department keeping their fingers crossed that they’ll cross the halfway mark by the start of the school holidays.
Also read:
Picture: Cape{town} etc gallery